Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience
Table 3
Demographic and clinical data.
Patient
1
2
3
4
5
6
7
8
9
Age gg
58
57
73
52
78
82
52
57
73
Gender
M
M
F
M
M
M
M
M
M
BMI (kg/m2)
29.1
30.2
26.4
39.4
32.2
27.4
31.1
34.6
22.7
Metabolic disease
HTN
DM
DM
DM HTN HL
DM HTN HL
HTN HL
HTN HL
DM HTN HL
DM HTN HL
Symptoms
No
No
No
No
No
No
Yes
No
Yes
Biopsy
No
No
Yes
Yes
Yes
Yes
No
Yes
Yes
AFP (ng/mL)
7.1
3.1
100.2
2.1
N.A.
7.4
311,190
9.3
2.5
ALT (IU/L)
60
44
52
N.A.
106
35
49
235
23
Albumin (g/dL)
4.3
3.9
4.2
4.5
3.6
4.3
3.6
3.3
3.7
Bilirubin (mg/dL)
1.1
1.0
0.8
0.3
1.3
1.0
0.8
0.5
0.5
Creatinine (mg/dL)
0.7
1.3
1.2
1.0
0.7
1.1
0.8
0.9
0.9
Platelet (×1000/L)
133
65
112
362
340
154
590
218
316
INR
1.0
1.3
0.9
1.0
1.1
1.0
1.1
0.9
1.1
CTP class
A
A
A
A
A
A
A
A
A
MELD score
6.6
9.0
7.2
7.3
6.4
6.8
6.9
6.4
6.9
BMI: body mass index, DM: diabetes mellitus, HTN: hypertension, HL: hyperlipidemia, AFP: alpha-fetoprotein, ALT: alanine aminotransferase, INR: international normalization ratio, CTP: Child-Turcotte-Pugh, MELD: model for end stage liver disease, N.A.: data not available.
